Fiche centre
The First Affiliated Hospital of Anhui Medical University
Hefei — China
Essais liés9clinical trials
VilleHefeilocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06349408
Essais cliniques associés
9| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Recombinant staphylokinase | Maladie coronarienne | Phase 4 | NCT05410925 | OPTIMA-6 — Efficacy and Safety of a Half-dose Bolus of r-SAK Prior to Primary PCI in ST-elevation Myocardial Infarction | RECRUITING |
| YTS109 cell | Lupus | Phase 1 | NCT07104721 | A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases | RECRUITING |
| ZL-1310 | Cancer | Phase 1 | NCT06179069 | A Study of ZL-1310 in Subjects With Small Cell Lung Cancer | RECRUITING |
| NK510 : allogeneic genetic modified NK | Lupus | Phase 1 | NCT07083349 | NK510 Cell Therapy for Refractory Systemic Lupus Erythematosus | TERMINATED |
| IBI3001 | Cancer | Phase 1 | NCT06349408 | IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors | RECRUITING |
| IPG11406 | Lupus | Phase 1/2 | NCT06717815 | Phase IIa Study for IPG11406 in Patients With Lupus Nephritis | COMPLETED |
| LVIVO-TaVec400 product | Myasthénie | Phase 1 | NCT07583030 | A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune Diseases | WITHDRAWN |
| Trontinemab | Alzheimer | Phase 3 | NCT07169578 | TRONTIER 1 — A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | ACTIVE_NOT_RECRUITING |
| The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease | Parkinson | Non applicable | NCT07572903 | The Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease | COMPLETED |